MARIETTA, Ga., Oct.12, 2015 /PRNewswire/ — MiMedx Group, Inc. MDXG, +5.32%the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and the Dental